These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 22952498)

  • 21. Prevalence of attention deficit hyperactivity disorder in schoolchildren in Athens, Greece. Association of ADHD subtypes with social and academic impairment.
    Skounti M; Giannoukas S; Dimitriou E; Nikolopoulou S; Linardakis E; Philalithis A
    Atten Defic Hyperact Disord; 2010 Nov; 2(3):127-32. PubMed ID: 21432598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of bone fractures among children and adolescents with attention-deficit/hyperactivity disorder: a systematic review and meta-analysis.
    Seens H; Modarresi S; MacDermid JC; Walton DM; Grewal R
    BMC Pediatr; 2021 Aug; 21(1):354. PubMed ID: 34412606
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psychopathological rating scales for diagnostic use in adults with attention-deficit/hyperactivity disorder (ADHD).
    Rösler M; Retz W; Thome J; Schneider M; Stieglitz RD; Falkai P
    Eur Arch Psychiatry Clin Neurosci; 2006 Sep; 256 Suppl 1():i3-11. PubMed ID: 16977549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A systematic review of comorbidity between cerebral palsy, autism spectrum disorders and Attention Deficit Hyperactivity Disorder.
    Craig F; Savino R; Trabacca A
    Eur J Paediatr Neurol; 2019 Jan; 23(1):31-42. PubMed ID: 30446273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Attention deficit hyperactivity disorder in children with primary monosymptomatic nocturnal enuresis: A case-control study.
    Yousefichaijan P; Sharafkhah M; Salehi B; Rafiei M
    Saudi J Kidney Dis Transpl; 2016 Jan; 27(1):73-80. PubMed ID: 26787570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of Autism Spectrum Disorder and Attention-Deficit Hyperactivity Disorder Amongst Individuals with Gender Dysphoria: A Systematic Review.
    Thrower E; Bretherton I; Pang KC; Zajac JD; Cheung AS
    J Autism Dev Disord; 2020 Mar; 50(3):695-706. PubMed ID: 31732891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Attention deficit hyperactivity disorder: a Rasch analysis of the SWAN Rating Scale.
    Young DJ; Levy F; Martin NC; Hay DA
    Child Psychiatry Hum Dev; 2009 Dec; 40(4):543-59. PubMed ID: 19455417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psychiatric comorbidity differences in clinic-referred children and adolescents with ADHD according to the subtypes and gender.
    Ghanizadeh A
    J Child Neurol; 2009 Jun; 24(6):679-84. PubMed ID: 19491114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Childhood Blood Lead Levels and Symptoms of Attention Deficit Hyperactivity Disorder (ADHD): A Cross-Sectional Study of Mexican Children.
    Huang S; Hu H; Sánchez BN; Peterson KE; Ettinger AS; Lamadrid-Figueroa H; Schnaas L; Mercado-García A; Wright RO; Basu N; Cantonwine DE; Hernández-Avila M; Téllez-Rojo MM
    Environ Health Perspect; 2016 Jun; 124(6):868-74. PubMed ID: 26645203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Parenting experiences of living with a child with attention deficit hyperactivity disorder: a systematic review of qualitative evidence.
    Laugesen B; Groenkjaer M
    JBI Database System Rev Implement Rep; 2015 Nov; 13(11):169-234. PubMed ID: 26657468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medical comorbidities in children and adolescents with autism spectrum disorders and attention deficit hyperactivity disorders: a systematic review.
    Muskens JB; Velders FP; Staal WG
    Eur Child Adolesc Psychiatry; 2017 Sep; 26(9):1093-1103. PubMed ID: 28674760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Massachusetts General Hospital studies of gender influences on attention-deficit/hyperactivity disorder in youth and relatives.
    Biederman J; Faraone SV
    Psychiatr Clin North Am; 2004 Jun; 27(2):225-32. PubMed ID: 15063995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estimation of prevalence of DSM-IV and latent class-defined ADHD subtypes in a population-based sample of child and adolescent twins.
    Neuman RJ; Sitdhiraksa N; Reich W; Ji TH; Joyner CA; Sun LW; Todd RD
    Twin Res Hum Genet; 2005 Aug; 8(4):392-401. PubMed ID: 16176725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of attention-deficit/hyperactivity disorder: a systematic review and meta-analysis.
    Thomas R; Sanders S; Doust J; Beller E; Glasziou P
    Pediatrics; 2015 Apr; 135(4):e994-1001. PubMed ID: 25733754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: a double-blind, placebo-controlled trial.
    Kelsey DK; Sumner CR; Casat CD; Coury DL; Quintana H; Saylor KE; Sutton VK; Gonzales J; Malcolm SK; Schuh KJ; Allen AJ
    Pediatrics; 2004 Jul; 114(1):e1-8. PubMed ID: 15231966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Attention-deficit/hyperactivity disorder in children with overactive bladder; a case-control study.
    Yousefichaijan P; Sharafkhah M; Rafiei M; Salehi B
    J Renal Inj Prev; 2016; 5(4):193-9. PubMed ID: 27689122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comorbidities and functional impairments in children with attention deficit hyperactivity disorder].
    Xiao ZH; Wang QH; Luo TT; Zhong L
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Sep; 15(9):728-32. PubMed ID: 24034913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of pharmaceutical therapy of ADHD (Attention-Deficit/Hyperactivity Disorder) in adults - health technology assessment.
    Benkert D; Krause KH; Wasem J; Aidelsburger P
    GMS Health Technol Assess; 2010 Sep; 6():Doc13. PubMed ID: 21289886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Attention Deficit Hyperactivity Disorder (ADHD) Subtypes, Co-Occurring Psychiatric Symptoms and Sexual Risk Behaviors among Adolescents Receiving Substance Abuse Treatment.
    Regan T; Tubman J
    Subst Use Misuse; 2020; 55(1):119-132. PubMed ID: 31502500
    [No Abstract]   [Full Text] [Related]  

  • 40. The distribution of symptoms of attention-deficit/hyperactivity disorder and oppositional defiant disorder in school age children in Turkey.
    Erşan EE; Doğan O; Doğan S; Sümer H
    Eur Child Adolesc Psychiatry; 2004 Dec; 13(6):354-61. PubMed ID: 15619047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.